Restart Life Sciences Corp.
HEAL
CNSX
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | 58.90% | -112,900.00% | -145.47% | -122.21% | -432.68% |
| Total Depreciation and Amortization | 866.67% | -25.00% | -25.00% | -25.00% | -25.00% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -78.87% | 15,963.64% | 107.71% | -- | -- |
| Change in Net Operating Assets | 790.77% | -3,840.00% | -21.81% | -4.95% | -117.98% |
| Cash from Operations | 67.48% | -2,782.72% | -1,636.36% | -690.14% | -377.84% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | 1,566.67% | -- | -- | -- |
| Total Debt Repaid | 93.98% | -- | -- | -- | -- |
| Issuance of Common Stock | -13.69% | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 2.06% | 12,221.50% | -- | -- | 631.24% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -303.53% | 41,626.92% | -1,636.36% | -690.14% | 1,482.35% |